Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Comprehensive Tobacco Cessation for Cancer Patients and Survivors

for
Tobacco Use Cessation, Cancer
Location: Richmond VA
Sponsor: Virginia Commonwealth University

Sex: All

Age: 18+

Code: NCT05805722

Recruiting

Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)

for
Cancer in Adolescence
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 15+

Code: NCT06950983

Recruiting

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

for
Solid Tumors
Location: East Brunswick NJ, New Brunswick NJ, Washington D.C. DC,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07123103

Phase 1, Recruiting

Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial

for
Lung Non-Small Cell Carcinoma
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06983899

Recruiting

COVID-19 Longitudinal Biomarkers in Lung Injury

for
Covid19, Respiratory Disease, Critical Illness
Location: Toronto
Sponsor: Dr. Andrew Baker

Sex: All

Age: 18+

Code: NCT04747782

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer

for
Lung Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70+

Code: NCT03563976

Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Advanced Breast Cancer
Location: Boston MA, New Haven CT, Fairfax VA, Huntersville NC,
Sponsor: Ensem Therapeutics

Sex: All

Age: 18+

Code: NCT06993844

Phase 1, Phase 2, Recruiting

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

for
Cancer, Occupational Therapy
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06329531

Recruiting

Rare Tumors and Cancer Predisposition in Individuals and Families

for
Cancer, Hereditary Neoplasms, Genetic Predisposition to Cancer,
Location: Bethesda MD, Rockville MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 70+

Code: NCT05350761

Recruiting

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

for
Solid Tumors
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06179160

Phase 1, Recruiting

Revealing Information Genuinely & Honestly Across Time - Communication Preferences Visit

for
Cancer, Communication
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 12+

Code: NCT06993688

Recruiting

Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures

for
Diabetes, Cancer, Multiple Sclerosis, Arthritis,
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18+

Code: NCT02777060

Recruiting

Merck IIT: RRP Pembro and Lenvatinib

for
Human Papilloma Virus, Recurrent Respiratory Papillomatosis,
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT04645602

Phase 2, Recruiting

Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis

for
Metastatic Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05059678

Recruiting

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

for
Cancer, Cancer Survivors, Gastrointestinal Cancers,
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT06908629

Recruiting

First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy

for
Non Small Cell Lung Cancer
Location: Detroit MI
Sponsor: Nerissa T. Viola

Sex: All

Age: 18+

Code: NCT06439914

Phase 1, Recruiting

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Boston MA, New Haven CT, Valhalla NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT06941272

Phase 1, Phase 2, Recruiting

PumaRx Registry Trial

for
Solid Tumors
Location: Burlington VT, Coral Gables FL, Pittsburgh PA
Sponsor: RenovoRx

Sex: All

Age: 18+

Code: NCT06805461

Recruiting

A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)

for
Non Small Cell Lung Cancer
Location: New York NY
Sponsor: Dizal Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06905197

Phase 1, Recruiting

Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)

for
Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06560398

Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial